- Home
- INM vs CNF Comparison
INM vs CNF Comparison
Compare INM & CNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INM | CNF |
|---|---|---|
| Founded | 1981 | 1999 |
| Country | Canada | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1M | 34.6M |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | INM | CNF |
|---|---|---|
| Price | $1.41 | $1.83 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 70.4K | 3.5K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.68 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,942,633.00 | N/A |
| Revenue This Year | N/A | $252.34 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.50 | N/A |
| 52 Week Low | $0.58 | $1.75 |
| 52 Week High | $2.50 | $6.49 |
Technical Indicators
Market Signals| Indicator | INM | CNF |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 34.94 |
| Support Level | N/A | N/A |
| Resistance Level | N/A | $2.35 |
| Average True Range (ATR) | 0.00 | 0.09 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 0.00 | 20.37 |
Price Performance
Historical ComparisonAbout INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
About CNF CNFinance Holdings Limited each representing twenty (20)
CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, the group generates all of its revenues in the PRC.